Citigroup is set to terminate employees who failed to get their COVID-19 vaccination. The investment banking company stated that if they are still unvaccinated by Jan. 14, they will immediately be placed on unpaid leave the eventually fired at the end of the month.
Employees can only retain their jobs in the company if they receive the vaccine before the set date. Those who have been granted an exemption for the jab will not be affected by the mandate.
As per Reuters, Citigroup made the announcement regarding the vaccination rule last week. With its new vaccination policy, the American bank has become the first major Wall Street company to follow through with the stern vaccine mandate.
It was said that Citigroup's move and decision to fire unvaccinated members of its workforce comes as the financial industry struggles to bring their employees safely back to offices and return to business as usual amid the spreading of the highly infectious Omicron coronavirus variant.
Citigroup will be enforcing its "no jab, no job" policy starting next week. Other major institutions on Wall Street, such as Goldman Sachs (GS), JPMorgan Chase, and Morgan Stanley (MS), have asked their unvaccinated employees to work from home, but none of them has opted to fire them.
On the other hand, other big firms in the U.S., including United Airlines and Google, are also willing to fire workers who fire who are not vaccinated yet. Then again, these companies have different rules on how unvaccinated staff would be fired as some give more time for workers to comply.
It was added that as of this time, over 90% of Citigroup's workers are already vaccinated and complied with the mandate. The vaccination policy was also implemented by US President Joe Biden's administration as it believes in the importance of the vaccine.
But the U.S. Supreme Court blocked Biden's policy to require employees to be vaccinated or tested weekly. "However, companies are recognizing that the Biden mandate may not hold up at the conservative Supreme Court," Professor at Columbia Business School, Adam Galinsky, said in a statement. "If it doesn't hold then they are going to have the decision put back in their hands and they will have to do something."


Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



